Methods for culturing organoids
The present invention provides a method for culturing organoids, the method comprising: a) disassociating unprocessed organoids to produce a cell suspension; b) sieving the cell suspension through a cell strainer to retain a sieved cell suspension containing cells of about 10 μm to about 1 mm in diameter; and c) seeding cells of the sieved cell suspension into a bioreactor in a cell culture medium comprising an extracellular support matrix.
1. A method for culturing organoids, the method comprising:
a) disassociating unprocessed organoids from primary cultures of tissue samples to produce a cell suspension;
b) sieving the cell suspension through a cell strainer to retain a sieved cell suspension containing cells of about 10 μm to about 1 mm in diameter;
c) seeding cells of the sieved cell suspension into a bioreactor in a cell culture medium comprising an extracellular support matrix;
d) culturing the cells in the bioreactor to form stage I organoids;
e) removing the stage I organoids from the bioreactor and suspending the stage I organoids in cell culture medium to form an organoid suspension; and
f) sieving the organoid suspension through at least two cell strainers having different mesh sizes to obtain a suspension of stage II organoids having a diameter of about 20 μm to about 200 μm.
2. The method of claim 1 , wherein the bioreactor is a perfusion bioreactor.
3. The method of claim 1 , wherein the bioreactor is a fed-plate bioreactor.
4. The method of claim of claim 1 , wherein the fed-plate bioreactor is a flat-bed bioreactor.
5. A method according to claim 3 , wherein the fed-plate bioreactor comprises an arrangement of bioreactors that are fed in parallel.
6. The method of claim 1 , wherein the cell culture medium comprises about 1% to about 99% v/v of the extracellular support matrix.
7. The method of claim 1 , wherein the cell culture medium comprises about 5% to about 85% v/v of the extracellular support matrix.
8. The method of claim 1 , wherein the extracellular support matrix is a solubilized basement membrane preparation.
9. The method of claim 1 , wherein the extracellular support matrix comprises laminin, entactin and collagen IV or laminin, entactin, collagen IV and heparin sulphate proteoglycan.
10. The method of claim 1 , wherein the cell strainer of step (b) has a mesh size of about 30 μm to about 50 μm.
11. The method of claim 1 , wherein step (e) comprises incubating the stage I organoids with cell recovery solution before suspending the organoids in cell culture medium.
12. The method of claim 1 , wherein the cell strainers of step (f) have mesh sizes of about 40 μm and about 85 μm.
13. The method of claim 1 , further comprising freezing the stage II organoids.